Literature DB >> 21170857

Open prostatectomy versus transurethral resection of the prostate, where are we standing in the new era? A randomized controlled trial.

Nasser Simforoosh1, Hamidreza Abdi, Amir Hossein Kashi, Samad Zare, Ali Tabibi, Abdolkarim Danesh, Abbas Basiri, Seyed Amir Mohsen Ziaee.   

Abstract

PURPOSE: To compare peri-operative and short-term complications of open transvesical prostatectomy (OP) as well as its functional outcomes with transurethral resection of the prostate (TURP) in management of benign prostatic hyperplasia with prostates sized 30 to 70 g.
MATERIALS AND METHODS: Hundred patients who were candidate for the prostate surgery with prostates between 30 to 70 g randomly underwent OP or TURP. Secondary endpoints included international prostate symptom score, residual urine volume, surgical complications, and patients' quality of life. Patients were followed up for 6 to 12 months after the operation.
RESULTS: Fifty-one and 49 patients underwent OP and TURP, respectively. Median (interquartile range) of peak flow rate improvement was 11.1 (7.6 to 14.2) and 8.0 (2.2 to 12.6) in OP and TURP groups, respectively (P = .02). International prostate symptom score improvement did not reveal statistically significant difference between treatment groups. Re-operation due to residual prostate lobe, urethral stricture, and urinary retention was performed in 8 patients in TURP group versus no patient in OP group (P = .006). Dysuria was more frequent in patients that underwent TURP (P < .001). Hospitalization duration was slightly longer in patients that underwent OP (P = .04). Patients' quality of life was better in the OP group (P = .04).
CONCLUSION: Open transvesical prostatectomy is an acceptable operation for the prostates sized 30 to 70 g. Higher peak flow rate improvement, better quality of life, less frequent dysuria, less need to re-operation, and its ease of learning make open prostatectomy a suitable option to be discussed in patients parallel to TURP.

Entities:  

Mesh:

Year:  2010        PMID: 21170857

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  6 in total

1.  Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate.

Authors:  Sundaram Palaniappan; Tricia Li Chuen Kuo; Christopher Wai Sam Cheng; Keong Tatt Foo
Journal:  Singapore Med J       Date:  2016-02-15       Impact factor: 1.858

2.  Dual-centre randomized-controlled trial comparing transurethral endoscopic enucleation of the prostate using diode laser vs. bipolar plasmakinetic for the treatment of LUTS secondary of benign prostate obstruction: 1-year follow-up results.

Authors:  Zhihui Zou; Abai Xu; Shaobo Zheng; Binshen Chen; Yawen Xu; Hulin Li; Chongyang Duan; Junhong Zheng; Jiasheng Chen; Chaoming Li; Yiming Wang; Yubo Gao; Chaozhao Liang; Chunxiao Liu
Journal:  World J Urol       Date:  2018-02-19       Impact factor: 4.226

3.  Standard surgical treatment for benign prostatic hyperplasia is safe for patients over 75 years: analysis of 100 cases from a high-volume urologic center.

Authors:  Rafael Marmiroli; Alberto A Antunes; Sabrina T Reis; Elcio Nakano; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

4.  Outcome of 980 nm diode laser vaporization for benign prostatic hyperplasia: A prospective study.

Authors:  M Hammad Mithani; Salman El Khalid; Shariq Anis Khan; Imran Sharif; Adnan Siddiq Awan; Shoaib Mithani; Irfan Majeed
Journal:  Investig Clin Urol       Date:  2018-10-18

5.  Surgical management of benign prostate hyperplasia in Nigeria: open prostatectomy versus transurethral resection of the prostate.

Authors:  Chimaobi Gideon Ofoha; John Edoka Raphael; Nuhu Kutan Dakum; Samaila Ibrahim Shu'aibu; Julius Akhaine; Isaac Musa Yaki
Journal:  Pan Afr Med J       Date:  2021-07-02

6.  A Retrospective Operative and Early Outcome Comparison of Suprapubic Transvesical Prostatectomy and Transurethral resection of the Prostate.

Authors:  Andualem Beyene; Abeselom Lemma; Seyfe Tilahun
Journal:  Ethiop J Health Sci       Date:  2021-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.